Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Alzheimer'S Disease : JAD
|
November 20, 2012
Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42
María Montañés, Diego Casabona, Leticia Sarasa, et al.
Neurobiology of Aging
|
April 16, 2013
Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry
Leticia Sarasa, José Antonio Allué, Pedro Pesini, et al.
International Journal of Alzheimer'S Disease
|
February 11, 2014
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome
Jesús Canudas, Daniel Insua, Leticia Sarasa, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease
José Antonio Allué, Leticia Sarasa, María Izco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 5, 2023
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study
José Antonio Allué, María Pascual-Lucas, Leticia Sarasa, et al.
Journal of Alzheimer'S Disease : JAD
|
July 26, 2014
Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's disease
Virginia Pérez-Grijalba, Pedro Pesini, José Antonio Allué, et al.
Frontiers in Aging Neuroscience
|
March 31, 2023
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
Min Young Chun, Hyemin Jang, Hee Jin Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
José Antonio Allué, Leticia Sarasa, María Pascual-Lucas, et al.
Frontiers in Aging Neuroscience
|
October 27, 2025
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment
José Antonio Allué, Leticia Sarasa, Noelia Fandos, et al.
Alzheimer'S Research & Therapy
|
October 23, 2021
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
Hyemin Jang, Ji Sun Kim, Hye Joo Lee, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Alzheimer'S Disease : JAD
|
November 20, 2012
Prevention of amyloid-β fibril formation using antibodies against the C-terminal region of amyloid-β1-40 and amyloid-β1-42
María Montañés, Diego Casabona, Leticia Sarasa, et al.
Neurobiology of Aging
|
April 16, 2013
Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry
Leticia Sarasa, José Antonio Allué, Pedro Pesini, et al.
International Journal of Alzheimer'S Disease
|
February 11, 2014
Neprilysin is poorly expressed in the prefrontal cortex of aged dogs with cognitive dysfunction syndrome
Jesús Canudas, Daniel Insua, Leticia Sarasa, et al.
Journal of Alzheimer'S Disease : JAD
|
June 4, 2016
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease
José Antonio Allué, Leticia Sarasa, María Izco, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
June 5, 2023
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study
José Antonio Allué, María Pascual-Lucas, Leticia Sarasa, et al.
Journal of Alzheimer'S Disease : JAD
|
July 26, 2014
Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's disease
Virginia Pérez-Grijalba, Pedro Pesini, José Antonio Allué, et al.
Frontiers in Aging Neuroscience
|
March 31, 2023
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity
Min Young Chun, Hyemin Jang, Hee Jin Kim, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
José Antonio Allué, Leticia Sarasa, María Pascual-Lucas, et al.
Frontiers in Aging Neuroscience
|
October 27, 2025
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment
José Antonio Allué, Leticia Sarasa, Noelia Fandos, et al.
Alzheimer'S Research & Therapy
|
October 23, 2021
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
Hyemin Jang, Ji Sun Kim, Hye Joo Lee, et al.
Page
of 2